Results 131 to 140 of about 1,784,951 (230)
Multiplex PCR to Diagnose Gastrointestinal Infections: Key Limitations in Interpretation
United European Gastroenterology Journal, Volume 14, Issue 7, September 2026.ABSTRACT Multiplex polymerase chain reaction (PCR) panels are increasingly used for the evaluation of acute diarrhea, providing rapid and sensitive detection of a broad range of enteric pathogens. However, their widespread adoption has created important interpretive challenges for clinicians.
Giannoula S. Tansarli, Ferric C. Fang
wiley +1 more source
Fecal microbiota transplantation: current clinical efficacy and future prospects
Clinical and Experimental Gastroenterology, 2015 Kathryn A Bowman,1 Elizabeth K Broussard,2 Christina M Surawicz2 1Department of Medicine, 2Division of Gastroenterology, University of Washington School of Medicine, Seattle, WA, USA Abstract: Fecal microbiota transplantation (FMT) has gained mainstream
Bowman KA, Broussard EK, Surawicz CM
doaj
Comprehensive Reviews in Food Science and Food Safety, Volume 25, Issue 5, September 2026.ABSTRACT Low water activity ingredients, including dried fruits, vegetables, herbs, and spices, are widely used in ready‐to‐eat (RTE) and non‐RTE foods. Although low water activity limits microbial growth, bacterial pathogens can survive for extended periods in these products.
Heidy M. W. den Besten +7 more
wiley +1 more source
Review Article: The Impact of the Gut Microbiome on Ulcerative Colitis Pharmacotherapy
Alimentary Pharmacology &Therapeutics, Volume 64, Issue 6, Page 729-747, September 2026.The gut microbiome modulates ulcerative colitis pharmacotherapy through microbial drug metabolism, immune regulation and altered drug bioavailability. Microbial composition influences response to aminosalicylates, corticosteroids, immunomodulators, biologics and small molecules, while microbiome‐targeted therapies show emerging promise.
Kate Collins +6 more
wiley +1 more source
Equine Veterinary Journal, Volume 58, Issue 5, Page 1363-1371, September 2026.Abstract Background Current treatment options for equine gastric ulcer syndrome (EGUS), such as omeprazole—a proton pump inhibitor (PPI)—have notable limitations, including the need for administration on an empty stomach. Potassium‐competitive acid blockers (P‐CABs), such as vonoprazan, are a newer class of acid suppressants that offer several ...
Camilo J. Morales +4 more
wiley +1 more source
Examination of the Prevalence, Genetic Diversity and Antibiotic Resistance of Clostridium Difficile (Clostridioides difficile) in Semi-Cooked Ready-to-Eat Products in the Sale Centers of Isfahan Province, Iran [PDF]
تحقیقات نظام سلامتBackground: Clostridium difficile (Clostridioides difficile) is known as one of the main causes of pseudomembranous colitis and is considered an important enteropathogen in humans.
Parvin Ghorbani +3 more
doaj
Antibiotics Associated With Clostridium difficile Infection. [PDF]
Cureus, 2023 Rafey A +6 more
europepmc +1 more source
Infection and Drug ResistanceYuyao Hao,1,* Jianhui Li,2,* Shoujun Xie,1 Yanchao Liu,1 Hainan Wen1,3 1Department of Clinical Laboratory, The Affiliated Hospital of Chengde Medical University, Chengde, Hebei, People’s Republic of China; 2Department of Preventive ...
Hao Y, Li J, Xie S, Liu Y, Wen H
doaj
Clostridium difficile infection in the elderly.
Le infezioni in medicina, 2013 The incidence of C. difficile infections (CDI) in the elderly continues to rise and infection is associated with increased morbidity and mortality when compared to those affected in younger age-groups. Immunosenescence may be a contributory factor yet the exact immune responses that may protect against CDI are incompletely understood.
Di Bella, Stefano +8 more
openaire +3 more sources
Point of care tests for hospital-acquired infections (HAIs) : economic analysis report [PDF]
A number of clinical/disease areas have been prioritised by the Technology Strategy Board (TSB) and Department of Health (DH) for the DIIA Innovation Platform.
Szczepura, Ala, Osipenko, Leeza
core